MENU
PVLA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Palvella Therapeutics (PVLA) Earnings Date & Reports
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies... Show more
A.I. Advisor
published Earnings
PVLA is expected to report earnings to fall 3.33% to -115 cents per share on August 13
Q2'26
Est.
$-1.16
Q1'26
Missed
by $0.71
Q4'25
Beat
by $0.04
Q3'25
Beat
by $1.10
Q2'25
Beat
by $1.17
The last earnings report on May 07 showed earnings per share of -120 cents, missing the estimate of -49 cents. With 36.76K shares outstanding, the current market capitalization sits at 1.70B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information